SIRT1 and renal cell carcinoma: Moreover, miR-22 suppressed EMT process and cancer distant metastasis by directly targeting TIAM1 (T-cell lymphoma invasion and metastasis 1) and SIRT1 in colorectal cancer and renal cell carcinoma, respectively38,39.